"Cancer Survivors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Persons who have experienced prolonged survival with or the following neoplastic disease and the impact of the disease on the individual, family members, and significant others.
| Descriptor ID |
D000073116
|
| MeSH Number(s) |
M01.860.350
|
| Concept/Terms |
Long-Term Cancer Survivors- Long-Term Cancer Survivors
- Cancer Survivor, Long-Term
- Cancer Survivors, Long-Term
- Long Term Cancer Survivors
- Long-Term Cancer Survivor
- Survivor, Long-Term Cancer
- Survivors, Long-Term Cancer
|
Below are MeSH descriptors whose meaning is more general than "Cancer Survivors".
Below are MeSH descriptors whose meaning is more specific than "Cancer Survivors".
This graph shows the total number of publications written about "Cancer Survivors" by people in this website by year, and whether "Cancer Survivors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 3 | 1 | 4 |
| 2017 | 6 | 4 | 10 |
| 2018 | 16 | 2 | 18 |
| 2019 | 23 | 3 | 26 |
| 2020 | 15 | 5 | 20 |
| 2021 | 18 | 1 | 19 |
| 2022 | 9 | 1 | 10 |
| 2023 | 12 | 1 | 13 |
| 2024 | 14 | 2 | 16 |
| 2025 | 12 | 4 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cancer Survivors" by people in Profiles.
-
Immune Reconstitution and Need for Booster Vaccinations Among Non-Transplant Childhood Cancer Survivors: A Single-Center Experience. Cancer Rep (Hoboken). 2025 Sep; 8(9):e70326.
-
Germline Pathogenic/Likely Pathogenic Mutations and Subsequent Neoplasms Among Childhood Cancer Survivors: A Report From the Children's Oncology Group ALTE03N1 Study. J Clin Oncol. 2025 Sep 20; 43(27):3011-3020.
-
Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors. JAMA Oncol. 2025 Aug 01; 11(8):835-845.
-
Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer. Ann Oncol. 2025 Oct; 36(10):1203-1211.
-
Examining the Relationship Between Dysphagia, Eating-Related Symptoms, and Diet Quality Among Oropharyngeal Cancer Patients During Critical Stages of Cancer Survivorship: The U-DINE Study. Head Neck. 2025 Oct; 47(10):2816-2826.
-
TTN and BAG3 in Cancer Therapy-Related Cardiomyopathy Among Long-Term Survivors of Childhood Cancer. JAMA Netw Open. 2025 06 02; 8(6):e2515793.
-
Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study. Lancet Oncol. 2025 Jun; 26(6):806-816.
-
Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy. J Clin Oncol. 2025 Jul; 43(19):2173-2183.
-
A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplar. Cancer. 2025 May 01; 131(9):e35857.
-
Temporal trends of subsequent central nervous system malignancies among survivors of childhood cancer. J Natl Cancer Inst. 2025 May 01; 117(5):1036-1045.